Identification of CβS and ODC antimony resistance markers in anthroponotic cutaneous leishmaniasis field isolates by

Farzaneh Zarrinkar1, Iraj Sharifi1, Razieh Tavakoli Oliaee1

  • 1Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

PubMed

Insights

Antiparasitic resistance in Leishmania tropica is a growing concern. This study found that cystathionine β-synthase (CβS) and ornithine decarboxylase (ODC) gene expression is elevated in resistant Leishmania tropica isolates.

Area of Science:

  • Medical Parasitology
  • Molecular Biology
  • Public Health

Background:

  • Antiparasitic resistance in Leishmania tropica poses a significant global health and economic challenge.
  • Understanding the molecular mechanisms of drug resistance is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate the expression of cystathionine β-synthase (CβS) and ornithine decarboxylase (ODC) in antimony-unresponsive versus responsive Leishmania tropica isolates.
  • To establish a link between CβS and ODC expression and antimony resistance in Leishmania tropica.

Main Methods:

  • Real-time PCR was used to quantify gene expression levels of CβS and ODC.
  • Leishmania tropica isolates were obtained from patients with cutaneous leishmaniasis in southeastern Iran.
  • Isolates were categorized as antimony-unresponsive or responsive based on treatment outcomes.

Main Results:

  • Both CβS and ODC genes were significantly up-regulated in antimony-unresponsive Leishmania tropica isolates compared to responsive ones.
  • The study identified a direct correlation between elevated CβS and ODC expression and antimony resistance in Leishmania tropica.
  • All patient isolates were confirmed to be Leishmania tropica.

Conclusions:

  • Cystathionine β-synthase (CβS) and ornithine decarboxylase (ODC) are key molecular markers associated with antimony resistance in Leishmania tropica.
  • Monitoring these gene markers can aid in the early detection of drug resistance.
  • Alternative therapeutic strategies, such as combination drug therapy, are recommended to combat the spread of resistant Leishmania tropica strains.